Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 20 Issue 7, July 2019

Focus on Adaptation

This month's Focus features a series of specially commissioned Reviews that discuss the metabolic and molecular mechanisms that allow immune cells and hematopoietic progenitor cells to adapt to diverse pathophysiological conditions or environments.

See: https://www.nature.com/collections/adaptation.

The original online version of the cover image contained a typographical error. This has now been corrected.

Cover Design: Erin Dewalt

Editorial

  • Adaptive behaviors in hematopoietic cells can promote homeostasis and enhance immune responses to pathogens, but they can also perpetuate the chronicity of inflammatory or metabolic disorders.

    Focus:

    Editorial

    Advertisement

Top of page ⤴

Comment

Top of page ⤴

Obituary

Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • Novel single-cell profiling technologies have delineated the cellular and molecular landscapes that dominate the joints in rheumatoid arthritis and the skin and kidneys in systemic lupus erythematosus, shedding light on potential pathogenic mechanisms.

    • Navin Varadarajan
    • Chandra Mohan
    News & Views
  • Although the molecular basis of most disease-associated single-nucleotide polymorphisms has remained elusive, an HIV-1 viral load–associated polymorphism (rs1015164) has been identified that marks expression of a long non-coding RNA that regulates the co-receptor CCR5 and thereby influences infection of CD4+ T cells.

    • Sanath Kumar Janaka
    • David T. Evans
    News & Views
  • The cytokine IL-15 controls the homeostasis and activation of CD8+ T cells and natural killer cells. A new study reveals the deubiquitinase Otub1 to be a negative regulator of IL-15 signaling, with important consequences for autoimmunity and anti-cancer immunity.

    • Paul N. Moynagh
    News & Views
Top of page ⤴

Review Articles

Top of page ⤴

Articles

Top of page ⤴

Resources

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links